Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160054/S125

HeartMate 3 Left Ventricular Assist System (LVAS)

ABBOTT MEDICAL · Decision date Jun 10, 2026

FDA DECISIONP160054/S125

What did the FDA approve?

FDA records P160054/S125 as a supplement to PMA P160054, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 10, 2026.

FDA approval order statement

Approval for alternate connector components for the connection interface between the user interface (UI) membrane and the main printed circuit board assembly (PCBA) of the HeartMate II (HMII) System Controller and HeartMate 3 (HM3) System Controller.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Jun 10, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P160054/S125
Regulatory pathway
PMA supplement
Product code
DSQ
Decision code
APPR
Decision date
Jun 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P160054. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160054 · Original PMA

    HeartMate 3 Left Ventricular Assist System

  2. P160054/S109 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  3. P160054/S111 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  4. P160054/S110 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  5. P160054/S104 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  6. P160054/S113 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  7. P160054/S094 · Related supplement

    HeartMate 3 Left Ventricular Assist System, HeartMate II Left Ventricular Assist System

  8. P160054/S112 · Related supplement

    HeartMate 3 Left Ventricular Assist System (LVAS)

  9. P160054/S116 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  10. P160054/S117 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  11. P160054/S118 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  12. P160054/S115 · Related supplement

    HeartMate 3 Left Ventricular Assist System (LVAS)

  13. P160054/S114 · Related supplement

    HeartMate 3 Left Ventricular Assist System (LVAS)

  14. P160054/S119 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  15. P160054/S120 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  16. P160054/S125 received

    Application receipt date recorded by FDA.

  17. P160054/S123 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  18. P160054/S124 · Related supplement

    HeartMate 3 Left Ventricular Assist System (LVAS)

  19. P160054/S122 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  20. P160054/S121 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  21. P160054/S125 · FDA decision

    Real-Time Process

  22. P160054/S127 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  23. P160054/S128 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  24. P160054/S129 · Related supplement

    HeartMate 3 Left Ventricular Assist System (LVAS)

  25. P160054/S130 · Related supplement

    HeartMate 3 Left Ventricular Assist System (LVAS)

  26. P160054/S131 · Related supplement

    HeartMate 3 Left Ventricular Assist System (LVAS)

  27. P160054/S133 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  28. P160054/S134 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  29. P160054/S136 · Related supplement

    HeartMate 3 Left Ventricular Assist System

Timeline entries are records held by MedtechLedger for P160054. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160054

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalAug 23, 2017FDA
ABBOTT MEDICALPMA supplementJul 17, 2025FDA
ABBOTT MEDICALPMA supplementAug 26, 2025FDA
ABBOTT MEDICALPMA supplementAug 27, 2025FDA
ABBOTT MEDICALPMA supplementOct 6, 2025FDA
ABBOTT MEDICALPMA supplementOct 9, 2025FDA
ABBOTT MEDICALPMA supplementOct 17, 2025FDA
ABBOTT MEDICALPMA supplementNov 4, 2025FDA
ABBOTT MEDICALPMA supplementDec 17, 2025FDA
ABBOTT MEDICALPMA supplementFeb 4, 2026FDA
ABBOTT MEDICALPMA supplementFeb 11, 2026FDA
ABBOTT MEDICALPMA supplementFeb 18, 2026FDA
ABBOTT MEDICALPMA supplementMar 2, 2026FDA
ABBOTT MEDICALPMA supplementMar 4, 2026FDA
ABBOTT MEDICALPMA supplementMar 4, 2026FDA
ABBOTT MEDICALPMA supplementMar 25, 2026FDA
ABBOTT MEDICALPMA supplementApr 2, 2026FDA
ABBOTT MEDICALPMA supplementMay 27, 2026FDA
ABBOTT MEDICALPMA supplementMay 29, 2026FDA
ABBOTT MEDICALPMA supplementJul 1, 2026FDA
ABBOTT MEDICALPMA supplementJul 9, 2026FDA
ABBOTT MEDICALPMA supplementJul 16, 2026FDA
ABBOTT MEDICALPMA supplementJul 30, 2026FDA
ABBOTT MEDICALPMA supplementAug 12, 2026FDA
ABBOTT MEDICALPMA supplementAug 20, 2026FDA
ABBOTT MEDICALPMA supplementSep 9, 2026FDA
HeartMate 3 LVASP160054/S135
ABBOTT MEDICALPMA supplementOct 1, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
AbbottPMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records